This result is to be compared with a recurrent amplification of 17p11.2 targeting TOP3A and mutually exclusive with ATRX deletion/mutations that has been identified in diffuse intrinsic pontine glioma with a H3.3‐K27M mutation (Mackay et al, 2017). The gene discussed is ATRX; the disease is diffuse intrinsic pontine glioma.